HOME ABOUT ▾ library contact order ABOUT NEUROAID ▸ CLINIcal studies ▸ safety profile ▸ Medical Professionals
composition & dosage ▸ Find out if neuroaid is right for you ABOUT NeuroAiD is an oral treatment helping victims of strokes and traumatic brain injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapies and exercises. Advancing Post-Stroke Care: Moleac at the J.P. Morgan Healthcare Conference
News

Advancing Post-Stroke Care: Moleac at the J.P. Morgan Healthcare Conference

By January 27, 2026February 2nd, 2026No Comments1 min read

We’re pleased to share that David Picard, CEO of Moleac, was recently interviewed at the J.P. Morgan Healthcare Conference in San Francisco.

In the interview, David discusses unmet needs in current care, particularly post-stroke care, and highlights the role of science in improving outcomes for neurological conditions.

Watch the interview: https://www.youtube.com/watch?v=ZMiA2pEFJdU

Thank you to the organizers of the J.P. Morgan Healthcare Conference for the opportunity to take part in these discussions.

Boston Consulting Group (BCG)